Asset
Zocilurtatug Pelitecan
Zai Lab Limited American Depositary Shares
Revenue
No revenue reported in loaded filings.
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT07218146 | phase3 | recruiting | 2025-11-30 | 2028-06-30 | Zai Lab (Shanghai) Co., Ltd. | A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE) |
| NCT06885281 | phase1_2 | recruiting | 2025-05-12 | 2027-08-01 | Zai Lab (Shanghai) Co., Ltd. | A Study of ZL-1310 in Participants With Selected Solid Tumors |
| NCT06179069 | phase1 | recruiting | 2024-01-23 | 2027-05-30 | Zai Lab (Shanghai) Co., Ltd. | A Study of ZL-1310 in Subjects With Small Cell Lung Cancer |
FDA applications (0)
This company has no applications containing this asset.